Evaluated by: David B. Kaminsky, M.D., FIAC, August 8, 2017 Original release date: August 8, 2017 Access to this course expires on: April 8, 2020 CME/SAMs 1.25
A. Arber, M.D.
This course will focus in the distinctive morphologic features of acute leukemia specimens and how they correlate with immunophenotypic and molecular genetic changes. The emphasis will be on the morphologic changes in acute myeloid leukemia and their correlation with diagnostic categories in the 2016 WHO classification of hematopoietic tumors as well as discussion of recent changes to the WHO classification.
Practicing academic and community pathologists, pathologists-in-training, hematopathologists.
Acute myeloid leukemia (AML) with recurrent genetic abnormalities
Role of gene mutations and dysplastic cellular changes in AML
Myeloid proliferations of Down syndrome
Recognize characteristic morphologic features associated with specific genetic abnormalities in acute myeloid leukemia
Understand the differential diagnosis of megakaryocytic proliferations in childhood
Understand the major gene mutations that impact diagnosis and prognosis in AML
earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing
score of 80%, they have the option to retake the exam. After you pass the test and complete the
evaluation, your certificate of completion will be available to view and print
by clicking here.